Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary involvement in systemic lupus erythematosus.

S Purice1, A Tudor, M Gheorghiu

  • 1N. Gh. Lupu Institute of Internal Medicine, Bucharest, Romania.

Medecine Interne
|October 1, 1987
PubMed
Summary

Systemic lupus erythematosus (SLE) frequently causes chronic lung disease, including pleurisy and interstitial pneumonia. Respiratory function tests reveal restrictive patterns and impaired gas exchange in affected patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Para-aminopropiophenone toxicity in domestic dogs: a description of non-target toxicosis in Victoria, Australia: 13 dogs (2016-2023).

Australian veterinary journal·2025
Same author

French national protocol for diagnosis and management of epidermal necrolysis in adults (Stevens-Johnson syndrome and toxic epidermal necrolysis).

Annales de dermatologie et de venereologie·2024
Same author

MALIGNANT PARAGANGLIOMA NON-RESPONSIVE TO MIBG IN MEN2A SYNDROME.

Acta endocrinologica (Bucharest, Romania : 2005)·2023
Same author

Ventricular-arterial coupling assessed by PWV/GLS ratio in hypertensive patients.

European review for medical and pharmacological sciences·2022
Same author

Selecting the right anticoagulant for stroke prevention in atrial fibrillation.

European review for medical and pharmacological sciences·2021
Same author

Probing insulators under pressure.

The Review of scientific instruments·2020

Area of Science:

  • Rheumatology
  • Pulmonology
  • Internal Medicine

Background:

  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease affecting multiple organs.
  • Pulmonary involvement is a significant complication of SLE, impacting patient morbidity and mortality.
  • Understanding the spectrum and functional consequences of lung disease in SLE is crucial for patient management.

Purpose of the Study:

  • To investigate the prevalence and types of pulmonary alterations in a large cohort of patients with SLE.
  • To characterize the respiratory function abnormalities associated with SLE-related lung disease.
  • To describe the clinical course and treatment of pulmonary involvement in SLE.

Main Methods:

  • Retrospective analysis of 608 patients hospitalized with SLE between 1974 and 1986.

Related Experiment Videos

  • Classification of pulmonary involvement into SLE-related and other etiologies.
  • Detailed respiratory function tests in a subgroup of patients.
  • Review of clinical data, organ involvement, and treatment modalities.

    • Main Results:

    • 18% of SLE patients exhibited pulmonary alterations attributable to SLE; 3.9% had other lung diseases.
    • Common SLE-related pulmonary manifestations included pleurisy, interstitial pneumonia, and diaphragmatic myopathy.
    • Respiratory function tests showed restrictive syndrome, reduced gas transfer, increased elastic recoil, and exercise-induced hypoxemia.
    • Pulmonary disease was chronic in 92% of cases, predominantly affecting females (94.1%).
    • Corticosteroids were the primary treatment in 60% of investigated cases.

    Conclusions:

    • Pulmonary involvement is a frequent and often chronic complication of SLE, necessitating comprehensive respiratory assessment.
    • SLE-related lung disease leads to significant functional impairment, including restrictive patterns and gas exchange abnormalities.
    • Effective management strategies, often involving corticosteroids, are essential for addressing pulmonary manifestations in SLE.